The NIL program serves as an opportunity for Dexcom to promote its glucose monitoring product, Dexcom CGM, alongside a portfolio of athletes who use it during training and athletic competitions.

With a new CEO taking over in 2026, Dexcom aims to stay ahead of its CGM competitors through a combination of innovation and product market expansion.

This is a Class I recall where 56 serious injuries have been reported. If you use one of Dexcom's continuous glucose monitoring systems, here's what you need to know.

Data from Dexcom CGMs will be integrated into FriskaAi and will be monitored by AI-powered algorithms that alert patients when action is advised.

This is a Class I recall where 56 serious injuries have been reported. If you use one of Dexcom's continuous glucose monitoring systems, here's what you need to know.